Document Detail


Anticoagulants in coronary artery disease.
MedLine Citation:
PMID:  18929235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Anticoagulant therapy for acute coronary syndromes is becoming more complex as newer agents are added to unfractionated heparin and warfarin. The anticoagulants used in current clinical practice are low molecular weight heparins, direct thrombin inhibitors, and heparinoids. Properties of and recent clinical trial data regarding these newer anticoagulants are reviewed in reference to current American College of Cardiology/American Heart Association guidelines.
Authors:
L Veronica Lee
Related Documents :
16466335 - Possible effect of thyroid function on anticoagulant response to unfractionated heparin.
18317045 - New british and american guidelines for the antibiotic prophylaxis of infective endocar...
9680105 - Evidence for sinoatrial blockade associated with high dose cytarabine therapy.
3929705 - Coronary bypass surgery in patients with circulating lupus anticoagulant.
16286175 - Cardiac resynchronization therapy improves heart rate profile and heart rate variabilit...
2970775 - Left ventricular function after successful percutaneous transluminal coronary angioplas...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  26     ISSN:  1558-2264     ISO Abbreviation:  Cardiol Clin     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-20     Completed Date:  2009-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  615-28     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Yale University School of Medicine, 789 Howard Avenue, FMP3, New Haven, CT 06437, USA. lveronica.lee@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Coronary Syndrome / drug therapy*
Angina, Unstable / drug therapy*
Anticoagulants / pharmacology,  therapeutic use*
Antithrombins / therapeutic use
Electrocardiography
Heparin / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Heparinoids / therapeutic use
Humans
Myocardial Infarction / drug therapy*,  physiopathology
Thrombolytic Therapy
Thrombosis / prevention & control
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Antithrombins; 0/Heparin, Low-Molecular-Weight; 0/Heparinoids; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythm...
Next Document:  Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronar...